Post-earnings recap
Reported
Wed, Nov 4, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp reported a better-than-expected EPS, but the stock fell by 4.08% in reaction. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The cautious tone from management may have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.42 | N/A | +5.00% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a cautious optimism about future performance. They acknowledged market challenges but emphasized their commitment to strategic initiatives.
Management highlighted ongoing efforts to improve operational efficiency.
They noted challenges in the market but expressed confidence in long-term growth.